BioCentury
ARTICLE | Financial News

Eidos, Avrobio propose NASDAQ IPOs

May 25, 2018 10:08 PM UTC

Eidos Therapeutics Inc. (Palo Alto, Calif.) and Avrobio Inc. (Cambridge, Mass.) proposed NASDAQ IPOs on Friday.

Eidos proposed to raise $115 million in an IPO underwritten by J.P. Morgan, BofA Merrill Lynch and Barclays...